This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Pain  • Surgery  • Surgical Interventions  • Orthopedic Surgery  • Alert me on articles by topic  Social Bookmarking   What's this?

Mario J. Cardoso, MD, DC; Daniel M. Sciubba, MD

Arch Surg. 2009;144(11):996-997.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

JAMA

Prevalence, Complications, and Hospital Charges Associated With Use of Bone-Morphogenetic Proteins in Spinal Fusion Procedures

Kevin S. Cahill, MD, PhD, MPH; John H. Chi, MD, MPH; Arthur Day, MD; Elizabeth B. Claus, MD, PhD

Context:  No national data exist to examine use of bone-morphogenetic proteins (BMPs) in spinal fusion surgery.

Objective:  To determine the patterns of use and rates of complications and financial charges associated with BMP use in spinal fusion nationally.

Design, Setting, and Patients:  Retrospective cohort study of 328 468 patients undergoing spinal fusion procedures from 2002-2006 identified from the Nationwide Inpatient Sample database, a 20% sample of US community hospitals.

Main Outcome Measures:  The rates of use of BMP among patients undergoing spinal fusion procedures are examined along with complications, length of stay, and hospital charges associated with use of this fusion adjunct.

Results:  The nationwide usage of . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter